Loading clinical trials...

18475 - Sun Protection Factor Assay | Clinical Trials | Clareo Health

COMPLETEDNA

18475 - Sun Protection Factor Assay

Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose

NCT02774252•Bayer

View on ClinicalTrials.gov

Summary

To evaluate the Sun Protection Factor efficacy on human skin.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.
•Male and female
•Aged between 18-70 years old.
•Good health as determined from the HRL SHF (Subject History Form)
•Signed and dated Informed Consent Form
•Signed and dated HIPAA (Health Insurance Portability and Accountability Act) form.
•An unambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose)

Exclusion Criteria

•Subjects on test at any other research laboratory or clinic.
•Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light.
•Pre-existing dermatologic conditions which have been diagnoses by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study.
•Pre-existing other medical conditions (e.g. adult asthma. diabetes).
•Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
•Treatment with antibiotics within two weeks prior to initiation of the test.
•Chronic medication which could affect the results of the study.
•Known pregnant or nursing women.

Locations (1)

Union, New Jersey, United States

Key Dates

Start Date

August 13, 2015

Primary Completion Date

September 3, 2015

Completion Date

September 3, 2015

Last Updated

December 12, 2018

Enrollment

ACTUAL participants

Conditions

Sunscreening Agents

Interventions

BAY987521

DRUG

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

NCT04355286

Absorption; ChemicalsSunscreening Agents

View study

COMPLETEDNA

Human Phototoxicity Test (823/2016)

NCT02962856

Sunscreening Agents

View study

COMPLETEDNA

Human Photoallergy Test (824/2016)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 12, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

18475 - Sun Protection Factor Assay

Inclusion Criteria

Exclusion Criteria

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

Human Phototoxicity Test (823/2016)

Human Photoallergy Test (824/2016)

Sun Protection Factor Assay (SPF Assay 200/2016)

Human Phototoxicity Test

Sun Protection Factor Assay